Abstract:Objective: Urinary tract infection is one of the most common extraintestinal infectious diseases encountered in clinics. It affects both genders and all age groups and constitutes a major health issue in clinical practice worldwide. Uropathogens often develop resistance to therapeutic agents, creating a formidable challenge for physicians to treat these infections. The goal of the current review is to provide current information on therapeutic advancements and interventions in the treatment of urinary tract infections. Materials and methods: Databases like MEDLINE, PubMed, and ClinicalTrials.gov were used as search engines to collect the relevant articles, and the required information was extracted. Results: Research data suggest an increasing prevalence of pathogenic strains that are resistant to standard antimicrobial regimens recommended for the treatment of urinary tract infections. Targeted therapies for urinary tract infections, such as mannosides and pilicides, as well as vaccinations against uropathogenic Escherichia coli, have been developed recently. The efficacy of other strategies like iontophoresis, hydrogel-coated catheters, and antibiofilm therapy is also investigated. Clinical trials conducted between 2014 and 2019 show a rise in interest in a variety of therapies, highlighting the need for a thorough strategy to treat urinary tract infections, particularly in populations of women. Conclusions: Antimicrobial-resistant strains of Escherichia coli are becoming more common in urinary tract infections, which have led to the development of targeted medicines such as mannosides and pilicides, as well as immunizations against the pathogenic Escherichia coli strains. There is continuing research into alternate approaches, such as hydrogel-coated catheters, antibiofilm therapy, and iontophoresis. Clinical trials conducted between 2014 and 2019 showed a rise in interest in these different treatment approaches.

Special Section on Therapeutic Approaches to Treat Disorders of the Urinary and Gastrointestinal Tracts--Editorial

Special Section on Medical Countermeasures, From Bench to Battlefield: Translating Experimental Therapies for Effective Combat Against Chemical Threats-Editorial

Editorial: Novel therapeutic targets for lower urinary tract symptoms

Editorial for GPR84 pharmacology

Introduction to the Theme "Novel Therapeutics with the Potential to Advance Health Care"

Special Section on Cannabinoid Signaling in Human Health and Disease--Editorial

Enhancing Clinical Efficacy Through the Gut Microbiota: A New Field of Traditional Chinese Medicine

INCLUDING TOXICOLOGICAL SCIENCES

50th Anniversary Celebration Collection Special Section on New and Emerging Areas and Technologies in Drug Metabolism and Disposition, Part II--Editorial

Editorial for the Special Issue: "Feature Papers in Drug Toxicity"

A systematic review of recent advances in urinary tract infection interventions and treatment technology

Pharmacologic Therapies in Gastrointestinal Diseases

Current and emerging pharmacological targets and treatments of urinary incontinence and related disorders

Special Issue: "Novel Diagnosis and Treatment of Gastrointestinal Disease"

Special Section on Therapeutic Implications for Sphingolipids in Health and Disease--Editorial

Emerging drugs for the treatment of ulcerative colitis

From Lab to Nature: Recent Advancements in the Journey of Gastroprotective Agents from Medicinal Chemistry to Phytotherapy

Urinary tract infections: microbial pathogenesis, host–pathogen interactions and new treatment strategies

Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects

Current Pharmacologic Options and Emerging Therapeutic Approaches for the Management of Ulcerative Colitis: A Narrative Review

Key Microbiological and Immunological Aspects